Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL1925467

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of PI3K subunit p110alpha assessed as formation of phosphatidylinositide-3-phosphate product formation after 30 mins by fluorescence polarization assay
10
Total Activities
10
Compounds Tested
2
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Confidence 8 — Homologous single protein target
Curated By Autocuration

Publication

Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer.
Sutherlin DP, Bao L, Berry M, Castanedo G, Chuckowree I, Dotson J, Folks A, Friedman L, Goldsmith R, Gunzner J, Heffron T, Lesnick J, Lewis C, Mathieu S, Murray J, Nonomiya J, Pang J, Pegg N, Prior WW, Rouge L, Salphati L, Sampath D, Tian Q, Tsui V, Wan NC, Wang S, Wei B, Wiesmann C, Wu P, Zhu BY, Olivero A.
J Med Chem (2011) 54 : 7579 -7587
PubMed 21981714 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 9 8.62 9.15
Ki 1 8.55 8.55

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL1922090 1 9.15
CHEMBL1922092 1 9.00
CHEMBL1922095 1 8.77
CHEMBL1083192 1 8.70
CHEMBL1922091 1 8.68
CHEMBL1922093 1 8.55
CHEMBL521851 PICTILISIB 2.0 1 8.52
CHEMBL1091978 1 8.40
CHEMBL1922094 APITOLISIB 2.0 1 8.32
CHEMBL1921986 1 8.06

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL1922090 IC50 = 0.7 nM 9.15
CHEMBL1922092 IC50 = 1.0 nM 9.00
CHEMBL1922095 IC50 = 1.7 nM 8.77
CHEMBL1083192 IC50 = 2.0 nM 8.70
CHEMBL1922091 IC50 = 2.1 nM 8.68
CHEMBL1922093 Ki = 2.8 nM 8.55
CHEMBL521851 PICTILISIB IC50 = 3.0 nM 8.52
CHEMBL1091978 IC50 = 4.0 nM 8.40
CHEMBL1922094 APITOLISIB IC50 = 4.8 nM 8.32
CHEMBL1921986 IC50 = 8.7 nM 8.06